Save Product
Product Details
Synonyms
CD22, SIGLEC2, BL-CAM, SIGLEC-2, Siglec2, SIGLEC2FLJ22814
Source
Human Siglec-2, His Tag (CD2-H52H8) is expressed from human 293 cells (HEK293). It contains AA Asp 20 - Arg 687 (Accession # P20273-1).
Predicted N-terminus: Asp 20
Request for sequenceMolecular Characterization
Other Tags and Version Biotin & Other Labeled Version
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 77.0 kDa. The protein migrates as 90-116 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
Endotoxin
Less than 0.01 EU per μg by the LAL method / rFC method.
Purity
>95% as determined by SDS-PAGE.
>95% as determined by SEC-MALS.
Formulation
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
Shipping and Storage
This product is shipped at ambient temperature.
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 6 months under sterile conditions after reconstitution.
ACRO Quality Management System
Customers Also Viewed
Performance Data
SDS-PAGE
Human Siglec-2, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).
SEC-MALS
The purity of Human Siglec-2, His Tag (Cat. No. CD2-H52H8) is more than 95% and the molecular weight of this protein is around 100-125 kDa verified by SEC-MALS.
Report
Bioactivity-ELISA
Immobilized Human Siglec-2, His Tag (Cat. No. CD2-H52H8) at 2 μg/mL (100 μL/well) can bind Anti-Human CD22 MAb with a linear range of 0.3-5 ng/mL (QC tested).
Protocol
Immobilized Human Siglec-2, His Tag (Cat. No. CD2-H52H8) at 2 μg/mL, add increasing concentrations of anti-CD22xCD19 scFv and then add Biotinylated Human CD19 (20-291), Fc,Avitag at 0.2 μg/mL. Detection was performed using HRP-conjugated streptavidin with sensitivity of 3.9 ng/mL (Routinely tested).
Protocol
Bioactivity-BLI
Loaded Anti-Human CD22 MAb (human IgG1) on AHC Biosensor, can bind Human Siglec-2, His Tag (Cat. No. CD2-H52H8) with an affinity constant of 133 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
Protocol
Evaluation of CAR expression
FACS Analysis of Anti-CD22 CAR Expression
293 cells were transfected with anti-CD22-scFv and RFP tag. 2e5 of the cells were first stained with B. Human Siglec-2, His Tag (Cat. No. CD2-H52H8, 3 μg/mL) and C. His Tag Protein Control, followed by FITC Anti-6xHis Tag Antibody. A. Non-transfected 293 cells and C. His Tag Protein Control were used as negative control. RFP was used to evaluate CAR (anti-CD22-scFv) expression and FITC was used to evaluate the binding activity of Human Siglec-2, His Tag (Cat. No. CD2-H52H8).
Protocol
Customer Reviews Writing Reviews
Background
Recent Advances
Drug Development Progress- English Name：
CD22
- Category：
- Approved Drugs：
2 Details
- Drugs in Clinical Trials：
73 Details
- Highest Development Stage：
Approved
Contact Us
メールアドレス
order.jp@acrobiosystems.com
お問い合わせ
グローバル：+1 800-810-0816(Toll Free)
Drug Candidate Licensing
